This is a great appointment, but personally i wouldn't be reading into it any more than that. IMU are in the ASX200 (at least for now), there would be very few, if any, of its peers in the 200 who didnt have a CFO, CCO or similar. If you are dealing with a billion dollar plus company you have to have some rigour and prudence around the financials, I think it is as simple as that. Hopefully I am incorrect and massive MA's and licencing agreements are afoot, but a little premature me thinks
Ann: Imugene appoints experienced life sciences CFO Mike Tonroe, page-39
Add IMU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
4.4¢ |
Change
-0.001(2.22%) |
Mkt cap ! $327.2M | |||
| Open | High | Low | Value | Volume |
| 4.5¢ | 4.6¢ | 4.4¢ | $358.2K | 7.968M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 25 | 3601437 | 4.4¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 4.5¢ | 671952 | 2 |
View Market Depth
| Last trade - 16.10pm 04/11/2024 (20 minute delay) ? |
| IMU (ASX) Chart |